These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 10469196)

  • 21. Suppression of Acid Secretion by Lansoprazole and its Effects on Helicobacter pylori. II. Poster presentations from the 2nd International Colloquium on Proton Pump Inhibitors. Houston, Texas, September 29, 1994.
    J Clin Gastroenterol; 1995; 20 Suppl 2():S1-135. PubMed ID: 7594319
    [No Abstract]   [Full Text] [Related]  

  • 22. Clarithromycin resistance in Helicobacter pylori: implications for therapy.
    Fujioka T
    J Gastroenterol; 2000; 35(1):69-70. PubMed ID: 10632546
    [No Abstract]   [Full Text] [Related]  

  • 23. Commentary: something new to consider in the treatment of Helicobacter pylori infection?
    Howden CW
    Aliment Pharmacol Ther; 2012 Aug; 36(4):399. PubMed ID: 22803645
    [No Abstract]   [Full Text] [Related]  

  • 24. The search for optimal Helicobacter pylori eradication regimen: a mid 1997 update.
    Deltenre M; De Bruyne L; Ntounda R; De Koster E; Lamy V
    Acta Gastroenterol Belg; 1998; 61(3):344-7. PubMed ID: 9795469
    [No Abstract]   [Full Text] [Related]  

  • 25. Drugs for GERD and peptic ulcer disease.
    Med Lett Drugs Ther; 2018 Jan; 60(1538):9-16. PubMed ID: 29309399
    [No Abstract]   [Full Text] [Related]  

  • 26. Helicobacter pylori: factors affecting eradication and recurrence.
    Vakil N
    Am J Gastroenterol; 2005 Nov; 100(11):2393-4. PubMed ID: 16279890
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proceedings of the 2nd International Colloquium on Proton Pump Inhibitors.
    J Clin Gastroenterol; 1995; 20 Suppl 1():S1-51. PubMed ID: 7673606
    [No Abstract]   [Full Text] [Related]  

  • 28. Commentary: overcoming antibiotic resistance with Helicobacter pylori therapy--optimisation is the way forward.
    Molina-Infante J; Gisbert JP
    Aliment Pharmacol Ther; 2013 Jul; 38(2):204-5. PubMed ID: 23772902
    [No Abstract]   [Full Text] [Related]  

  • 29. Commentary: something new to consider in the treatment of Helicobacter pylori infection? Authors' reply.
    Nseir W; Mograbi J; Abu-Elheja O
    Aliment Pharmacol Ther; 2012 Aug; 36(4):399-400. PubMed ID: 22803646
    [No Abstract]   [Full Text] [Related]  

  • 30. Comparison of vonoprazan and proton pump inhibitors for eradication of Helicobacter pylori.
    Shinozaki S; Nomoto H; Kondo Y; Sakamoto H; Hayashi Y; Yamamoto H; Lefor AK; Osawa H
    Kaohsiung J Med Sci; 2016 May; 32(5):255-60. PubMed ID: 27316584
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Helicobacter pylori diagnostics and treatment: could a lack of universal consensus be the best consensus?
    Couturier MR; Marshall BJ; Goodman KJ; Mégraud F
    Clin Chem; 2014 Apr; 60(4):589-94. PubMed ID: 23908455
    [No Abstract]   [Full Text] [Related]  

  • 32. [The role of Helicobacter pylori in occurrence of the digestive system pathologic processes].
    Polinkevych BS; Pikas PB
    Klin Khir; 2014 Jun; (6):66-9. PubMed ID: 25252560
    [No Abstract]   [Full Text] [Related]  

  • 33. Helicobacter pylori eradication: proton pump inhibitor vs. ranitidine bismuth citrate plus two antibiotics for 1 week-a meta-analysis of efficacy.
    Gisbert JP; González L; Calvet X; Roqué M; Gabriel R; Pajares JM
    Aliment Pharmacol Ther; 2000 Sep; 14(9):1141-50. PubMed ID: 10971230
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Which proton pump inhibitor should we use?
    Williams CN
    Can J Gastroenterol; 1997; 11(1):29. PubMed ID: 9113794
    [No Abstract]   [Full Text] [Related]  

  • 35. Maastricht II treatment scheme and efficacy of different proton pump inhibitors in eradicating Helicobacter pylori.
    Altintas E; Sezgin O; Ulu O; Aydin O; Camdeviren H
    World J Gastroenterol; 2004 Jun; 10(11):1656-8. PubMed ID: 15162544
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacological therapy used in the elimination of Helicobacter pylori infection: a review.
    Dos Santos AA; Carvalho AA
    World J Gastroenterol; 2015 Jan; 21(1):139-54. PubMed ID: 25574087
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Proton pump blockade and Helicobacter pylori: status of current knowledge and clinical importance].
    Labenz J; Börsch G
    Leber Magen Darm; 1992 Sep; 22(5):169-72. PubMed ID: 1406011
    [No Abstract]   [Full Text] [Related]  

  • 38. Twelve-month endoscopic and histological analysis following proton-pump inhibitor-based triple therapy in Helicobacter pylori-positive patients with gastric ulcers.
    Tulassay Z; Stolte M; Engstrand L; Butruk E; Malfertheiner P; Dítê P; Tchernev K; Wong BC; Gottlow M; Eklund S; Wrangstadh M; Herszényi L; Nagy P;
    Scand J Gastroenterol; 2010 Sep; 45(9):1048-58. PubMed ID: 20509752
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Commentary: overcoming antibiotic resistance with Helicobacter pylori therapy--optimisation is the way forward; authors' reply.
    Sierra F; Forero JD; Rey M; Botero ML; Cárdenas A
    Aliment Pharmacol Ther; 2013 Jul; 38(2):205-6. PubMed ID: 23772903
    [No Abstract]   [Full Text] [Related]  

  • 40. Management of Helicobacter pylori infection.
    Costa F; D'Elios MM
    Expert Rev Anti Infect Ther; 2010 Aug; 8(8):887-92. PubMed ID: 20695744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.